Quantifying Bacterial Shedding to Evaluate Infection Transmission Potential in Drosophila
JoVE Encyclopedia of Experiments
Microbiology
0 views • 2:02 min • January 30th, 2026
Begin with a Drosophila fly previously infected by a gut-colonizing bacterial pathogen.
Transfer the fly into a sterile tube containing a fly food medium.
Leave the fly undisturbed to feed on the food.
Inside the fly gut, the pathogenic bacteria utilize the nutrients from the food and multiply.
When the fly excretes, some bacteria are also released.
After a fixed period, transfer the fly into a fresh tube with food and repeat the process multiple times.
Then, discard the fly from the last tube.
Add a buffer to each tube and vortex to release bacteria from the fly excreta.
Prepare serial dilutions of the recovered solution from each tube.
Spot the diluted solutions onto a nutrient agar plate and incubate to allow bacterial colonies to grow.
Count the colonies to determine the number of viable bacteria shed by the infected fly over time, which reflects its potential to transmit infection.
To measure bacterial shedding, transfer single flies to 1.5 milliliter tubes containing about 50 microliters of Lewis medium.
Change the tube every 24 hours. After three tubes have been populated for 24 hours, dispose of the flies. After each transfer, measure the bacteria contained in the tube.
Mix the tube content with 100 microliters of PBS using a vortex. Then measure the CFUs in the mixture by plating serial dilutions.
Overview
This study investigates the shedding of pathogenic bacteria by Drosophila flies infected with a gut-colonizing bacterial pathogen. The methodology involves transferring infected flies to sterile environments and measuring bacterial colonies to assess transmission potential.
Key Study Components
Area of Science
- Microbiology
- Infectious Diseases
- Entomology
Background
- Drosophila serves as a model organism for studying gut microbiota interactions.
- Understanding bacterial shedding is crucial for assessing infection transmission.
- Pathogenic bacteria can exploit nutrients from the host's diet.
- Previous studies have shown the importance of host-pathogen dynamics.
Purpose of Study
- To quantify the number of viable bacteria shed by infected Drosophila.
- To understand the potential for transmission of bacterial pathogens.
- To develop a method for measuring bacterial excretion over time.
Methods Used
- Infected flies are transferred to sterile tubes with food.
- Flies are allowed to feed and excrete bacteria into the medium.
- Buffer is added to recover bacteria from excreta.
- Serial dilutions are plated on nutrient agar to count colonies.
Main Results
- Viable bacteria were successfully recovered from the excreta of infected flies.
- The method allowed for quantification of bacterial shedding over time.
- Results indicate a significant potential for transmission of infection.
- Flies shed bacteria consistently across multiple feeding cycles.
Conclusions
- The study provides insights into the dynamics of bacterial shedding in Drosophila.
- Findings contribute to understanding host-pathogen interactions.
- This method can be applied to further research on bacterial transmission.
Frequently Asked Questions
Executive Industry Relevance
Quantifying bacterial shedding in model organisms provides a measurable proxy for infection transmission potential, supporting early-stage target validation in antimicrobial development. This approach enables mechanistic de-risking by linking pathogen load in host excretions to environmental spread risk, informing go/no-go decisions in lead identification pipelines. The method supports predictive confidence in preclinical models by standardizing quantitative readouts of pathogen excretion over time.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Measures viable pathogen excretion to assess transmission potential and validate therapeutic hypotheses.
- Operational Value: Provides a reproducible workflow for tracking bacterial load dynamics in host systems.
- Strategic Value: Supports target prioritization by quantifying shedding reduction as a functional readout of intervention efficacy.
Screening & Assay Development
- Scientific Value: Generates quantitative CFU data from serial dilution and plating to enable dose-response profiling.
- Operational Value: Standardizes sample recovery via buffer vortex and dilution plating for cross-assay consistency.
- Strategic Value: Creates a scalable screening platform for evaluating compounds that reduce pathogen shedding.
Translational & Preclinical Research
- Scientific Value: Links gut pathogen burden to excretion levels, supporting disease-relevant system modeling.
- Operational Value: Enables longitudinal monitoring across multiple host cycles to assess sustained transmission risk.
- Strategic Value: Informs preclinical advancement decisions by measuring impact on shedding as a biomarker of transmission-blocking potential.
Pipeline & Workflow Integration
The method fits within early discovery to preclinical transition, where shedding quantification serves as a functional biomarker for transmission-blocking candidates.
- Discovery Biology: Supports hypothesis testing on pathogen-host interactions by measuring excretion as an output of gut colonization and virulence.
- Screening: Delivers reproducible, quantitative CFU readouts per timepoint to rank compound effects on shedding.
- Analytics: Enables statistical comparison of shedding trajectories across conditions using colony count data from serial dilutions.
- Translational Research: Connects shedding reduction to transmission risk, aligning with biomarker strategies for infection control.
- Enterprise Reuse: Establishes a standardized shedding assay adaptable across vector-borne and gastrointestinal pathogen programs.
Operational & Enterprise Impact
- Scientific Value: Provides mechanistic insight into pathogen excretion dynamics, reducing ambiguity in transmission modeling.
- Operational Value: Ensures reproducibility through standardized fly transfer, recovery, and plating steps.
- Strategic Value: Improves capital efficiency by enabling early prioritization of compounds that demonstrably reduce shedding.
- Portfolio Impact: Supports risk-adjusted advancement by linking shedding reduction to lower transmission potential in disease models.
Implementation Considerations
- Requires expertise in microbiological plating, serial dilution, and CFU enumeration.
- Dependent on sterile tubing, nutrient agar, and vortexing equipment for bacterial recovery.
- Necessitates cross-team standardization of transfer timing and dilution protocols for data comparability.
- Adaptation to alternative models requires validation of bacterial recovery efficiency from excretory matrices.
- Practical limitations include variability in host excretion behavior and the need for consistent feeding conditions across replicates.
Biopharma FAQs
Systemic Bacterial Infection and Immune Defense Phenotypes in Drosophila Melanogaster
Related Videos
0 Views
Establishment of Viral Infection and Analysis of Host-Virus Interaction in Drosophila Melanogaster
Related Videos
0 Views
Drosophila melanogaster Larva Injection Protocol
Related Videos
0 Views
Quantitative Measurement of the Immune Response and Sleep in Drosophila
Related Videos
0 Views
Counting Colony Forming Units (CFUs): Quantifying Bacteria from Fly Bodies
Related Videos
0 Views
Quantification of Colony-Forming Units of Gut-Associated Bacteria in Drosophila Flies
Related Videos
0 Views
Oral Infection of Drosophila melanogaster with Pathogenic Bacteria
Related Videos
0 Views
Measuring E. coli Bacterial Load in Drosophila melanogaster following E. coli Infection
Related Videos
0 Views
Assay to Determine the Virus Infectious Dose of Drosophila C Virus in Cultured Insect Cells
Related Videos
0 Views
An In Vivo Assay to Quantify Bacterial Phagocytosis in Adult Drosophila Flies
Related Videos
0 Views
Last updated: 22 August 2026